Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NCK1 | P16333 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9927345 | 0.72 | NQO2 (0.85) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL2756741 | 0.72 | NQO2 (0.85) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL6028972 | 0.72 | NQO2 (0.43) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL21512319 | 0.72 | CYP1A2 (0.48) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL8400097 | 0.72 | NQO2 (0.43) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL38660824 | 0.70 | LMNA (0.52) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL21131352 | 0.70 | NQO2 (0.81) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL2756743 | 0.70 | CYP1A2 (0.46) | NQO2LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL8749320 | 0.70 | NQO2 (0.52) | NQO2CYP1A2ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL18609173 | 0.70 | CYP1A2 (0.50) | NQO2LMNACYP1A2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11751475-B2 | Organic compound, display panel and display apparatus | XIAMEN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| WO-2017040993-A1 | SMALL MOLECULE INHIBITORS OF DYRK1A AND USES THEREOF | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11751475-B2 | Organic compound, display panel and display apparatus | C3AR1, NR0B2, NR0B1 | NQO2 3819/4885LMNA 2613/4885CYP1A2 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.